Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemia
Open Access
- 1 March 2004
- journal article
- Published by American Society of Hematology in Blood
- Vol. 103 (5) , 1909-1911
- https://doi.org/10.1182/blood-2003-07-2577
Abstract
Aberrant expression of transcription factor oncogenes such as HOX11, HOX11L2, TAL1/SCL, LYL1, LMO1, and LMO2 can be detected in lymphoblasts from up to 80% of patients with acute T-cell lymphoblastic leukemia (T-ALL). Transcriptional activation of these oncogenes in leukemic cells typically results from chromosomal rearrangements that place them next to highly active cis-acting transcriptional regulatory elements. However, biallelic activation of TAL1 in some T-ALL cases has been previously proposed. We have used allele-specific mRNA analysis to show that trans-acting mechanisms leading to biallelic overexpression of TAL1 are involved in 10 (42%) of 24 TAL1+ informative T-ALL cases, 2 (17%) of 12 HOX11+ informative cases, and 7 (64%) of 11 LMO2+ informative cases. We propose that aberrant expression of oncogenic transcription factors in a significant fraction of T-ALLs may result from loss of the upstream transcriptional mechanisms that normally down-regulate the expression of these oncogenes during T-cell development.Keywords
This publication has 7 references indexed in Scilit:
- Expression of HOX11 in childhood T-lineage acute lymphoblastic leukaemia can occur in the absence of cytogenetic aberration at 10q24: a study from the Children's Cancer Group (CCG)Leukemia, 2003
- Development of αβ T cells in the human thymusNature Reviews Immunology, 2002
- Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemiaCancer Cell, 2002
- Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemiaSeminars in Hematology, 2000
- Promoter demethylation accompanies reactivation of theHOX11 proto-oncogene in leukemiaGenes, Chromosomes and Cancer, 2000
- SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-Tα chain expressionNature Immunology, 2000
- Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group studyBlood, 1993